ENDRA Life Sciences logo

ENDRA Life SciencesNASDAQ: NDRA

Profile

Sector:

Healthcare

Country:

United States

IPO:

30 June 2017

Next earnings report:

28 March 2025

Last dividends:

N/A

Next dividends:

N/A
$2.64 M
-93%vs. 3y high
7%vs. sector
-vs. 3y high
-vs. sector
-90%vs. 3y high
23%vs. sector
-vs. 3y high
-vs. sector

Price

after hours | Thu, 21 Nov 2024 00:57:29 GMT
$5.10$0.00(0.00%)

Dividend

No data over the past 3 years
No data over the past 3 years

Analysts recommendations

Institutional Ownership

NDRA Latest News

ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update
businesswire.com15 November 2024 Sentiment: POSITIVE

ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three and nine months ended September 30, 2024 and provided a business update. Highlights from the third quarter and recent weeks include: Developed data analysis features for TAEUS platform by introducing new models rooted in artificial intelligence (AI), machine learning (ML) and deep learning (DL). As part of its conti.

ENDRA Life Sciences Inc. (NDRA) Q2 2024 Earnings Call Transcript
seekingalpha.com22 August 2024 Sentiment: NEUTRAL

ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q2 2024 Earnings Conference Call August 22, 2024 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Alexander Tokman - Acting CEO Ziad Rouag - Head of Regulatory and Clinical Affairs Michael Thornton - Chief Technology Officer Richard Jacroux - CFO Conference Call Participants Edward Woo - Ascendiant Capital Operator Good afternoon, and welcome to the ENDRA Life Sciences Second Quarter 2024 Financial Results Conference Call. All participants will be in listen-only mode.

ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering
businesswire.com04 June 2024 Sentiment: POSITIVE

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (Nasdaq: NDRA) (“ENDRA” or the “Company”), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announced today that it has priced a public offering with gross proceeds to the Company expected to be approximately $8.0 million, before deducting placement agent fees and other estimated expenses payable by the Company. The offering is a best-efforts offering, with no minimum amount of securities required to be sold. The offering is.

AM Best to Host Webinar on Engaging Defense Counsel Pre-Lawsuit
businesswire.com04 June 2024 Sentiment: POSITIVE

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best will host a complimentary webinar titled “The Case for Engaging Defense Counsel Pre-Lawsuit,” on June 25, 2024, at 2:00 p.m. ET. In this webinar, sponsored by Three Griffins, Inc., a panel of insurance claims experts will examine the path from claim to lawsuit, and best practices on minimizing loss through appropriate legal consultation. Register now. Panelists include: Daniel Herbert, president/CEO, Three Griffins, Inc. Donald J. Richardson, shareholder,.

ENDRA Life Sciences Inc. (NDRA) Q1 2024 Earnings Call Transcript
Seeking Alpha14 May 2024 Sentiment: POSITIVE

ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q1 2024 Earnings Call Transcript May 14, 2024 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Francois Michelon - Chairman and CEO Michael Thornton - Chief Technology Officer Irina Pestrikova - Senior Director of Finance Conference Call Participants Edward Woo - Ascendiant Capital Operator Welcome to the ENDRA Life Sciences First Quarter 2024 Financial Results Conference call. All participants will be in a listen-only mode.

ENDRA Life Sciences Inc. (NDRA) Q4 2023 Earnings Call Transcript
Seeking Alpha28 March 2024 Sentiment: NEUTRAL

ENDRA Life Sciences Inc. (NDRA) Q4 2023 Earnings Call Transcript

ENDRA Life Sciences Inc. (NDRA) Q3 2023 Earnings Call Transcript
Seeking Alpha14 November 2023 Sentiment: POSITIVE

ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q3 2023 Results Conference Call November 14, 2023 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Francois Michelon - Chairman and Chief Executive Officer Michael Thornton - Chief Technology Officer Irina Pestrikova - Senior Director, Finance Conference Call Participants Edward Woo - Ascendiant Capital Operator Good day, and welcome to the ENDRA Life Sciences Third Quarter 2023 Financial Results Conference Call. All participants will be in a listen-only mode.

ENDRA Life Sciences Inc. (NDRA) Q2 2023 Earnings Call Transcript
Seeking Alpha14 August 2023 Sentiment: POSITIVE

ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Francois Michelon - Chairman and Chief Executive Officer Michael Thornton - Chief Technology Officer Irina Pestrikova - Senior Director, Finance Conference Call Participants Edward Woo - Ascendiant Capital Operator Good day, and welcome to the ENDRA Life Sciences Second Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode.

ENDRA Life Sciences Inc. (NDRA) Q1 2023 Earnings Call Transcript
Seeking Alpha15 May 2023 Sentiment: POSITIVE

ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Francois Michelon - Chairman & Chief Executive Officer Michael Thornton - Chief Technology Officer Irina Pestrikova - Senior Director of Finance Conference Call Participants Edward Woo - Ascendiant Capital Operator Good day, and welcome to the ENDRA Life Sciences Inc. First Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode.

What type of business is ENDRA Life Sciences?

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

What sector is ENDRA Life Sciences in?

ENDRA Life Sciences is in the Healthcare sector

What industry is ENDRA Life Sciences in?

ENDRA Life Sciences is in the Diagnostics & Research industry

What country is ENDRA Life Sciences from?

ENDRA Life Sciences is headquartered in United States

When did ENDRA Life Sciences go public?

ENDRA Life Sciences initial public offering (IPO) was on 30 June 2017

What is ENDRA Life Sciences website?

https://endrainc.com

Is ENDRA Life Sciences in the S&P 500?

No, ENDRA Life Sciences is not included in the S&P 500 index

Is ENDRA Life Sciences in the NASDAQ 100?

No, ENDRA Life Sciences is not included in the NASDAQ 100 index

Is ENDRA Life Sciences in the Dow Jones?

No, ENDRA Life Sciences is not included in the Dow Jones index

When was ENDRA Life Sciences the previous earnings report?

No data

When does ENDRA Life Sciences earnings report?

The next expected earnings date for ENDRA Life Sciences is 28 March 2025